×

Teva drug patent invalidated by US regulator

3:35 PM ET Wed, 24 Aug 2016

Shares of Teva Pharmaceutical Industries are plunging, as U.S. patent offices invalidated their drug patent. CNBC's Meg Tirrell reports.